Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
Journal of Immunology Research|November 21, 2015
Cellular and Antibody Based Approaches for Pediatric Cancer ImmunotherapyMichael A Huang, Deepa K Krishnadas, Kenneth G LucasHuman Vaccines & Immunotherapeutics|June 2, 2016
Dendritic cell vaccines: A review of recent developments and their potential pediatric applicationJennifer D Elster, Deepa K Krishnadas, Kenneth G LucasLeukemia Research|July 22, 2011
Wilms' tumor 1-specific cytotoxic T lymphocytes can be expanded from adult donors and cord bloodDeepa K Krishnadas, Mindy M Stamer, Kimberly Dunham, et al.Cancer Immunology, Immunotherapy : CII|June 25, 2015
A phase I trial combining decitabine/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcomaDeepa K Krishnadas, Suzanne Shusterman, Fanqi Bai, et al.International Immunology|February 10, 2007
Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral bloodJustin S Ahn, Deepa K Krishnadas, Babita AgrawalVaccine|January 5, 2010
HCV-core and NS3 antigens play disparate role in inducing regulatory or effector T cells in vivo: Implications for viral persistence or clearanceDeepa K Krishnadas, Wen Li, Rakesh Kumar, et al.Cellular Immunology|July 21, 2009
In vitro activation and differentiation of naïve CD4+ and CD8+ T cells into HCV core- and NS3-specific armed effector cells: a new role for CD4+ T cellsDeepa K Krishnadas, Wen Li, Rakesh Kumar, et al.International Immunology|April 23, 2010
Immunomodulation by hepatitis C virus-derived proteins: targeting human dendritic cells by multiple mechanismsDeepa K Krishnadas, Justin S Ahn, Jiang Han, et al.International Immunology|November 17, 2007
Priming and stimulation of hepatitis C virus-specific CD4+ and CD8+ T cells against HCV antigens NS4, NS5a or NS5b from HCV-naive individuals: implications for prophylactic vaccineWen Li, Deepa K Krishnadas, Rakesh Kumar, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2006
Induction of primary human T cell responses against hepatitis C virus-derived antigens NS3 or core by autologous dendritic cells expressing hepatitis C virus antigens: potential for vaccine and immunotherapyWen Li, Deepa K Krishnadas, Jie Li, et al.Pageof 4